Treprostinil derivative compounds and methods of using same

US9371264B2 · kind B2 · utility

Assignee

• Corsair Pharma, Inc. · US

Inventors

• Cyrus K. BECKER · Fremont, US
• Jurg R. Pfister · Los Altos, US
• Gwenaella Rescourio · Thousand Oaks, US
• Meenakshi S. Venkatraman · Fremont, US
• Xiaoming Zhang · Beijing, CN

Key dates

• Filing date: Jan 13, 2014
• Grant date: Jun 21, 2016
• Expiry date: Jan 13, 2034

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07C2603/14
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Compounds represented by formulae I, II, III, and IV including pro-drugs for treprostinil and prostacyclin analogs. Uses include treatment of pulmonary hypertension (PH) or pulmonary arterial hypertension (PAH). The structures of the compounds can be adapted to the particular application for a suitable treatment dosage. Transdermal applications can be used.